Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hirokazu Miyatake is active.

Publication


Featured researches published by Hirokazu Miyatake.


European Journal of Radiology | 2010

Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma—Cooling effect by endoscopic nasobiliary drainage tube

Tsuneyoshi Ogawa; Hirofumi Kawamoto; Yoshiyuki Kobayashi; Shinichiro Nakamura; Hirokazu Miyatake; Ryo Harada; Koichiro Tsutsumi; Masakuni Fujii; Naoko Kurihara; Hironari Kato; Ken Hirao; Osamu Mizuno; Etsuji Ishida; Hiroyuki Okada; Kazuhide Yamamoto

BACKGROUND AND STUDY AIMS Biliary stricture after radiofrequency ablation (RFA) for nodules of hepatocellular carcinoma (HCC) close to major bile ducts sometimes causes septic complications and liver failure. Therefore, it may require interventional drainage for decompression during the follow-up period. The purpose of this study is to clarify the feasibility and safety of bile duct cooling using an endoscopic nasobiliary drainage (ENBD) tube in RFA for HCC close to major bile ducts. PATIENTS AND METHODS Between August 2003 and July 2007, 14 consecutive patients (14 nodules) undergoing RFA with cooling by an ENBD tube for HCCs close to major bile ducts were enrolled in this study. We infused chilled saline solution via the ENBD tube at 1ml/s to prevent heat damage during RFA. As controls, 11 patients (13 nodules) undergoing RFA without cooling close to major bile ducts between April 2001 and August 2003 were reviewed. The major outcomes for evaluation were biliary complications and the secondary outcome was local tumor recurrence. RESULTS There were no significant differences in tumor recurrence between the two groups. However, the rate of biliary complications was significantly lower in the cooling group than in the non-cooling group (0% vs. 39%, P=0.02). CONCLUSIONS Cooling of bile ducts via an ENBD tube can prevent biliary complications induced by RFA of HCC close to major bile ducts without increasing local recurrence. This technique increases indication of RFA in difficult cases.


Digestion | 2010

Large waist circumference is a risk factor for reflux esophagitis in Japanese males.

Hisae Yasuhara; Yasuhiro Miyake; Tatsuya Toyokawa; Kazuyuki Matsumoto; Masahiro Takahara; Takayuki Imada; Satoru Yagi; Hirokazu Miyatake; Morihito Nakatsu; Masaharu Ando; Mamoru Hirohata

Background/Aims: The prevalence of reflux esophagitis, which might lead to development of Barrett’s esophagus and esophageal adenocarcinoma, has been increasing. The aim of this study was to assess risk factors for reflux esophagitis. Methods: We conducted a cross-sectional study of 1,495 Japanese subjects undergoing health checkups (822 males and 673 females; median age 50 years) at a tertiary care center. Results: One hundred and twenty-seven subjects (8%) had reflux esophagitis and hiatal hernia was observed in 292 subjects (20%). Reflux esophagitis (13 vs. 3%) and hiatal hernia (28 vs. 9%) were more frequent in males than females. Significant differences in clinical backgrounds were observed between females and males. Multivariate logistic regression analyses revealed that hiatal hernia (OR 6.63, 95% CI 2.47–17.8; p = 0.0002) was associated with reflux esophagitis in females. In males, age (per 1-year increment: OR 0.96, 95% CI 0.94–0.99; p = 0.007), hiatal hernia (OR 3.16, 95% CI 2.05–4.87; p < 0.0001) and waist circumference (per 1-cm increase: OR 1.09, 95% CI 1.02–1.15; p = 0.006) were associated with reflux esophagitis. Conclusions: Abdominal obesity may be an important risk factor for reflux esophagitis in males compared with females.


Journal of Gastroenterology and Hepatology | 2017

Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis

Anna Seki; Fusao Ikeda; Hirokazu Miyatake; Koichi Takaguchi; Shosaku Hayashi; Toshiya Osawa; Shin Ichi Fujioka; Ryoji Tanaka; Masaharu Ando; Hiroyuki Seki; Yoshiaki Iwasaki; Kazuhide Yamamoto; Hiroyuki Okada

It remains unclear whether primary biliary cholangitis (PBC) represents a risk factor for secondary osteoporosis.


Internal Medicine | 2018

Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma

Yoshitaka Takuma; Iwadou Shota; Hirokazu Miyatake; Shuji Uematsu; Ryouichi Okamoto; Yasuyuki Araki; Hiroyuki Takabatake; Youichi Morimoto; Hiroshi Yamamoto

Objective The purpose of this study was to construct nomograms for the disease-free survival (DFS) and overall survival (OS) of post-radiofrequency ablation (RFA) patients with hepatocellular carcinoma (HCC). Furthermore, we compared the prognostic predictive ability of these nomograms for estimating per-patient outcomes with that of traditional staging systems. Methods We retrospectively enrolled 298 patients in the training set and 272 patients in the validation set who underwent RFA for HCC. The nomograms for the DFS and OS were constructed from the training set using the multivariate Cox proportional hazards model. The discriminatory accuracy of the models was compared with traditional staging systems by analyzing the Harrells C-index. Results The DFS nomogram was developed based on the tumor size, tumor number, aspartate aminotransferase (AST), albumin, age, and α-fetoprotein. The OS nomogram was developed based on the tumor size, the model for end-stage liver disease, AST, and albumin. Our DFS and OS nomograms had good calibration and discriminatory abilities in the training set, with C-indexes of 0.640 and 0.692, respectively, that were greater than those of traditional staging systems. The C-indexes of our DFS and OS nomograms were also greater than those of traditional staging systems in the validation set, with C-indexes of 0.614 and 0.657, respectively. RFA patients were stratified into low- and high-risk groups based on the median nomogram scores. High-risk patients receiving surgical resection (SR) were associated with a better DFS and OS than those undergoing RFA. However, the DFS and OS were similar between the low-risk RFA and SR groups. Conclusion We constructed reliable and useful nomograms that accurately predict the DFS and OS after RFA for early-stage HCC patients. These graphical tools are easy to use and will assist physicians during the therapeutic decision-making process.


International Journal of Clinical Oncology | 2011

Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

Hiroaki Hagihara; Kazuhiro Nouso; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shinichiro Nakamura; Kenji Kuwaki; Junichi Toshimori; Hirokazu Miyatake; Hideki Ohnishi; Hidenori Shiraha; Kazuhide Yamamoto


Internal Medicine | 2000

Churg-Strauss syndrome with pleural involvement

Shoji Hirasaki; Tadashi Kamei; Yoko Iwasaki; Hirokazu Miyatake; Ikuko Hiratsuka; Atsushi Horiike; Yuko Ogita; Yoshiko Matsuhashi; Shuhei Yamamoto


Digestive Diseases and Sciences | 2012

Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Hirokazu Miyatake; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shin Ichiro Nakamura; Hideki Ohnishi; Kenji Kuwaki; Junichi Toshimori; Hiroaki Hagihara; Kazuhiro Nouso; Kazuhide Yamamoto


Digestive Diseases and Sciences | 2012

Peppermint Oil Solution Is Useful as an Antispasmodic Drug for Esophagogastroduodenoscopy, Especially for Elderly Patients

Atsushi Imagawa; Hidenori Hata; Morihito Nakatsu; Yasunari Yoshida; Keiko Takeuchi; Toshihiro Inokuchi; Takayuki Imada; Yoshiyasu Kohno; Masahiro Takahara; Kazuyuki Matsumoto; Hirokazu Miyatake; Satoru Yagi; Masaharu Ando; Mamoru Hirohata; Shigeatsu Fujiki; Ryuta Takenaka


World Journal of Gastroenterology | 2009

A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B

Kazuyuki Matsumoto; Yasuhiro Miyake; Hirokazu Miyatake; Masahiro Takahara; Takayuki Imada; Satoru Yagi; Tatsuya Toyokawa; Morihito Nakatsu; Masaharu Ando; Mamoru Hirohata


Internal Medicine | 2000

Pulmonary lymphangiomyomatosis (LAM) developing chylothorax.

Naofumi Morimoto; Shoji Hirasaki; Tadashi Kamei; Atsushi Horiike; Hirokazu Miyatake; Yuko Ogita; Hideharu Nakano

Collaboration


Dive into the Hirokazu Miyatake's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge